Evidence map›Paper›PMID 42700155›Full record

ArticleEpilepsia open2026

Quantifying extra-lesional interhemispheric cortical asymmetry in focal cortical dysplasia type II.

Faezeh Heidari, Mastaneh Torkamani-Azar, Jussi Tohka, Reetta Kälviäinen

Abstract read
In one paragraph

Article in Epilepsia open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Faezeh HeidariDepartment of Neurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.ORCID https://orcid.org/0000-0002-8044-3068
Mastaneh Torkamani-AzarA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.ORCID https://orcid.org/0000-0001-6172-7842
Jussi TohkaA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.ORCID https://orcid.org/0000-0002-1048-5860
Reetta KälviäinenDepartment of Neurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.ORCID https://orcid.org/0000-0003-2935-5131

Funding

European Union's Horizon 2020 101034307Jane and Aatos Erkko FoundationResearch Council of Finland (Flagship of Advanced Mathematics for Sensing Imaging and Modelling) 358944
6 · The paper itself

Abstract

objectiveFocal cortical dysplasia type II (FCDII) is a cortical malformation representing a common cause of surgically treatable drug-resistant epilepsy. We studied whether FCDII disrupts normal structural interhemispheric asymmetry beyond the lesion location and quantified these asymmetries derived from structural magnetic resonance imaging (MRI) between individuals with FCDII and healthy controls (HC) as well as within FCDII subtypes using surface-based morphometry (SBM).

methodsUsing an open MRI dataset from University Hospital Bonn, we processed T1-weighted images from HC and individuals with FCDII aged over 15 years at the time of scan. We designed a three-stage workflow consisting of SBM using FreeSurfer, visual inspection of atlas-based cortical parcellations, and lesion projection. We extracted five cortical measures of intensity, thickness, volume, curvature, and surface area from 34 regions of interest (ROIs) and computed unsigned interhemispheric asymmetry indices beyond the lesion location.

resultsThe majority of FCDII lesions annotated in the original dataset were located in the frontal lobe (64.0%). Compared to the HC, individuals with MRI-diagnosed FCDII showed significantly reduced unsigned interhemispheric intensity asymmetry across parietal, temporal, and occipital cortices (q < 0.001). We observed an increase in the unsigned interhemispheric volume asymmetry in the lateral orbitofrontal cortex and in the unsigned interhemispheric surface-area asymmetry in the inferior temporal cortex for FCDII compared to HC (q < 0.001). Subtype analyses revealed greater unsigned interhemispheric intensity asymmetry in caudal anterior cingulate and superior temporal cortices in FCDIIb compared with FCDIIa (q < 0.001). Conversely, precentral unsigned surface-area and volume asymmetries were smaller in FCDIIb relative to FCDIIa (q < 0.001). We observed no significant differences for unsigned interhemispheric cortical thickness and curvature asymmetries after multiple-comparison corrections. SIGNIFICANCE: SBM-derived interhemispheric asymmetry captures cortical alterations in FCDII beyond the focal lesions. Observed differences in group-level unsigned interhemispheric intensity, volume, and surface-area asymmetry indicated cortical alterations that are consistent with distributed cortical involvement between FCDIIa and FCDIIb. These findings may enhance presurgical evaluation by highlighting cortical areas outside the primary lesion that could contribute to seizure generation and achieving seizure-freedom after the operation. PLAIN LANGUAGE SUMMARY: Focal cortical dysplasia type II (FCDII) is a malformation of cortical development associated with drug-resistant epilepsies. FCDII may disrupt normal cortical interhemispheric asymmetries which are understudied in focal, extratemporal epilepsies. We discovered that individuals with FCDII display altered structural cortical interhemispheric asymmetries in intensity, volume, and surface area compared to healthy volunteers, with each FCDII subtype exhibiting a distinct pattern of disrupting the natural asymmetries. Since extra-lesional abnormalities may contribute to incomplete seizure control after surgery, these interhemispheric asymmetry findings could provide complementary information for presurgical evaluations.

Indexed as

cortexepilepsyfocal cortical dysplasiainterhemispheric asymmetry

Identifiers

PMID42700155
PMCPMC13545978

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.